Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Return on Equity (2016 - 2025)

Iradimed (IRMD) has disclosed Return on Equity for 12 consecutive years, with 0.26% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 33.0% to 0.26% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.26% through Dec 2025, up 33.0% year-over-year, with the annual reading at 0.28% for FY2025, 35.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.26% at Iradimed, up from 0.04% in the prior quarter.
  • The five-year high for Return on Equity was 0.26% in Q4 2025, with the low at 0.07% in Q4 2024.
  • Average Return on Equity over 5 years is 0.14%, with a median of 0.19% recorded in 2022.
  • The sharpest move saw Return on Equity fell -30bps in 2024, then skyrocketed 33bps in 2025.
  • Over 5 years, Return on Equity stood at 0.14% in 2021, then grew by 28bps to 0.18% in 2022, then surged by 32bps to 0.24% in 2023, then crashed by -128bps to 0.07% in 2024, then soared by 490bps to 0.26% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.26%, 0.04%, and 0.05% for Q4 2025, Q3 2025, and Q2 2025 respectively.